Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $311.02 | $19.27 | 1,513.81% | 6,220.40x | 93.23x | 6.89x | 8.34x | 6.01x | $529.27M | 1.54% | $4.13B | 37.48 | $32.32B | 101.62 | ||
| CORT | CORCEPT THERAPEUTICS INC | $38.20 | $43.13 | -11.44% | 38.20x | 34.76x | 5.34x | 6.36x | 0.37x | $162.57M | 4.11% | $631.90M | 6.10 | $3.90B | 59.10 | ||
| NVO | NOVO NORDISK A S | $52.39 | $148.91 | -64.82% | 14.57x | 2.27x | 4.79x | 8.89x | 0.15x | $9.34B | 4.01% | $26.18B | 5.89 | $243.45B | 9.81 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $400.17 | $36.78 | 988.15% | 1,290.87x | 57.50x | 16.39x | 226.03x | 4.19x | $221.36M | 0.42% | $233.89M | 1.78 | $54.59B | 359.33 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $42.01 | $17.35 | 142.11% | 85.72x | 24.41x | 5.25x | 5.95x | 1.06x | $101.73M | 3.24% | $535.38M | 7.17 | $3.02B | 56.34 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.34 | $16.44 | -49.26% | 17.38x | 14.67x | 5.53x | 3.53x | 0.22x | -$23.64M | -5.07% | $133.17M | 2.38 | $477.80M | 7.11 | ||
| VCEL | VERICEL CORP | $35.61 | $9.55 | 272.97% | 136.96x | 61.25x | 6.95x | 5.60x | 1.62x | $20.38M | 1.13% | $321.86M | 6.38 | $1.80B | 61.36 | ||
| ARGX | ARGENX SE | $839.99 | $362.35 | 131.82% | 33.57x | 28.46x | 27,096.45x | 7.15x | 1.41x | $467.72M | 0.91% | $7.17B | 117.50 | $48.86B | 60.23 | ||
| KRYS | KRYSTAL BIOTECH INC | $246.91 | $115.85 | 113.12% | 35.78x | 30.77x | 19.16x | 6.29x | 1.19x | $166.02M | 2.32% | $1.14B | 39.30 | $6.78B | 35.06 | ||
| GMAB | GENMAB A | $31.82 | $128.15 | -75.17% | 13.58x | 1.82x | 5.73x | 3.55x | 0.10x | $1.19B | 5.85% | $5.75B | 8.96 | $18.81B | 9.40 | ||
| TECH | BIO-TECHNE CORP | $59.65 | $16.30 | 265.99% | 119.30x | 29.50x | 7.62x | 4.73x | 1.63x | $224.06M | 2.42% | $1.97B | 12.65 | $9.54B | 43.20 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $190.11 | $72.39 | 162.64% | 82.30x | 22.59x | 14.82x | 3.94x | 1.18x | $30.76M | 0.83% | $950.17M | 48.53 | $4.05B | 39.35 | ||
| ADMA | ADMA BIOLOGICS INC | $17.88 | $12.74 | 40.39% | 20.32x | 19.92x | 8.73x | 9.87x | 0.85x | $40.73M | 0.96% | $431.19M | 1.81 | $4.27B | 24.79 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.31 | $19.12 | -72.23% | 3.34x | -98.52x | 758.57x | 1.68x | 0.20x | -$82.36M | -28.59% | $171.23M | 3.16 | $228.64M | 2.54 | ||
| MNKD | MANNKIND CORP | $5.60 | $2.78 | 101.25% | 56.00x | 51.05x | 5.47x | -38.60x | 0.93x | $43.39M | 2.52% | -$44.55M | -0.15 | $1.95B | 26.67 | ||
| VCYT | VERACYTE INC | $42.39 | $12.34 | 243.57% | 108.69x | 40.29x | 6.74x | 2.66x | 1.54x | $98.21M | 2.94% | $1.26B | 15.98 | $3.07B | 53.94 | ||
| RPRX | ROYALTY PHARMA PLC | $38.86 | $47.26 | -17.78% | 22.08x | 7.50x | 7.14x | 2.33x | 0.38x | $2.11B | 12.58% | $9.62B | 22.28 | $30.44B | 29.15 | ||
| CRMD | CORMEDIX INC | $12.16 | $17.84 | -31.84% | 5.36x | 4.83x | 4.31x | 2.56x | 0.93x | $74.42M | 8.06% | $374.13M | 4.93 | $1.06B | 9.43 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.25 | $4.33 | 44.49% | 23.15x | 20.77x | 4.00x | 7.06x | 0.83x | $21.15M | 4.24% | $70.68M | 0.89 | $437.55M | 19.28 | ||
| EXEL | EXELIXIS INC | $43.58 | $36.60 | 19.06% | 17.72x | 13.79x | 5.11x | 5.41x | 0.71x | $779.77M | 6.67% | $2.16B | 8.05 | $11.48B | 12.38 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $452.13 | $190.61 | 137.20% | 31.60x | 22.11x | 9.86x | 6.62x | 1.53x | $3.34B | 2.89% | $17.32B | 67.76 | $111.61B | 23.94 | ||
| HALO | HALOZYME THERAPEUTICS INC | $70.31 | $80.86 | -13.04% | 14.38x | 8.48x | 6.63x | 16.41x | 0.49x | $602.40M | 7.31% | $503.92M | 4.30 | $9.36B | 11.07 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.74 | $3.58 | -51.34% | 24.86x | 9.84x | 2.23x | 2.64x | 0.20x | -$11.69M | -8.45% | $52.91M | 0.67 | $134.46M | 15.16 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $59.45 | $51.46 | 15.54% | 21.86x | 13.19x | 3.69x | 1.89x | 0.61x | $832.13M | 7.29% | $6.06B | 31.54 | $10.77B | 13.94 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $25.86 | $6.68 | 286.92% | 73.89x | -23.28x | 3.22x | 8.16x | 2.03x | $78.64M | 2.41% | $401.17M | 3.17 | $3.27B | 34.99 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $15.35 | $9.85 | 55.80% | 26.47x | 16.10x | 7.61x | 5.53x | 0.86x | $119.87M | 5.92% | $365.77M | 2.78 | $2.03B | 19.60 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $37.38 | $61.29 | -39.01% | 11.57x | 8.85x | 2.60x | 2.58x | 0.32x | $296.89M | 13.80% | $835.12M | 14.51 | $1.67B | 6.21 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $23.15 | $22.66 | 2.15% | 12.93x | 11.87x | 4.91x | 3.09x | 0.69x | $234.54M | 8.26% | $920.25M | 7.51 | $2.16B | 6.66 | ||
| MDXG | MIMEDX GROUP INC | $6.48 | $5.06 | 27.96% | 23.14x | 25.93x | 2.44x | 4.02x | 0.69x | $66.82M | 6.96% | $238.95M | 1.61 | $835.83M | 12.08 | ||
| INVA | INNOVIVA INC | $19.87 | $19.41 | 2.38% | 10.51x | 9.09x | 3.53x | 1.47x | 0.85x | $196.54M | 14.32% | $1.01B | 14.63 | $1.27B | 5.90 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $776.31 | $413.02 | 87.96% | 17.87x | 16.85x | 5.64x | 2.64x | 1.75x | $4.22B | 5.25% | $30.96B | 298.82 | $81.79B | 14.32 | ||
| UTHR | UNITED THERAPEUTICS CORP | $496.72 | $251.65 | 97.39% | 17.44x | 16.69x | 6.95x | 3.25x | 2.07x | $1.12B | 5.16% | $6.59B | 150.46 | $20.05B | 11.31 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $26.29 | $12.37 | 112.53% | 16.75x | 32.65x | 4.24x | 4.85x | 2.89x | $197.81M | 4.46% | $917.27M | 5.43 | $4.22B | 14.68 | ||
| INCY | INCYTE CORP | $101.42 | $77.44 | 30.97% | 16.79x | 12.60x | 4.12x | 4.28x | 0.87x | $1.20B | 6.03% | $4.65B | 23.77 | $17.49B | 10.39 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.